Humacyte, Inc. (HUMA) Analysis

According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Alright fellow degenerates, come gather round. I've found a spicy little biotech stock with solid potential. She's low float, highly shorted, and looking for a good time ;) $HUMA (Humacyte inc.) got FDA approval a few months back to basically pull off some Frankenstein shit. They're growing blood vessels in test tubes to help our troops. America baby! Recently they got added to the DoD's list of suppliers, and earlier today they confirmed sales. They're also 25% short according to Fintel. With...